SEC Form 4 · accession 0001209191-15-005886
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce I Sachs
Director
Period of report
Jan 20, 2015
Accepted (ET)
Jan 22, 2015 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 20, 2015 | M | 139 | $28.40 | A | 21,349 | D | |
| Common Stock | Jan 20, 2015 | S | 139 | $125.00 | D | 21,210 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $28.40 | Jan 20, 2015 | M | 139 | D | — | May 31, 2018 | Common Stock | 139 | 0 | D |
Explanation of responses
- F1Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.
- F2Fully vested.